Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Erleada(apalutamide)安森珂(阿帕他胺)

Treated patients with non-metastatic castration-resistant prostate cancer (nmCRPC) demonstrate robust prostate-specific antigen (PSA) responses and high medication compliance rates

Share: